arrow
返回
K

K. Govind Babu

Kidwai Memorial Institute of Oncology

12H指数
57论文数
605被引数
收录论文 9
发表时间
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
err2023-02-01
err12
errOAAI
errKoppikar, S.; Oaknin, A.; Babu, K. Govind; Lorusso, D.; Gupta, S.; Wu, L. -Y.; Rajabto, W.; Harano, K.; Hong, S. -h.; Malik, R. A.; Strebel, H.; Aggarwal, I. M.; Lai, C. -H.; Dejthevaporn, T.; Tangjitgamol, S.; Cheng, W. F.; Chay, W. Y.; Benavides, D.; Hashim, N. M.; Moon, Y. W.; Yunokawa, M.; Anggraeni, T. D.; Wei, W.; Curigliano, G.; Maheshwari, A.; Mahantshetty, U.; Sheshadri, S.; Peters, S.; Yoshino, T.; Pentheroudakis, G.
err分享
err收藏
Correlation between work productivity loss and EORTC QLQ-C30 and-BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2-advanced breast cancer
err2022-02-28
err4
errOAAI
errTripathy, Debu; Curteis, Tristan; Hurvitz, Sara; Yardley, Denise; Franke, Fabio; Babu, K. Govind; Wheatley-Price, Paul; Im, Young-Hyuck; Pencheva, Radost; Eddowes, Lucy A.; Dionne, Pierre-Alexandre; Chandiwana, David; Pathak, Purnima; Lanoue, Brad; Harbeck, Nadia
err分享
err收藏
Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib
err2021-02-15
err14
PREAI
errTripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De laurentiis, Michelino; Im, Young-Hyuck; Kummel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Kaur, Sharonjeet; Gasch, Claudia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Lu, Yen-Shen; Liu, Mei-Ching
err分享
err收藏
Efficacy and safety of ceritinib 450 mg-fed vs 750 mg-fasted in Asian patients (pts) with ALK plus non-small cell lung cancer (NSCLC) in the ASCEND-8 trial
err2020-09-01
err0
errOAAI
errCho, B. C. Chul; Kim, D-W.; Batra, U.; Park, K.; Kim, S-W.; Yang, C. T.; Jye, V. Pie; Sriuranpong, V.; Babu, K. G.; Amin, K.; Wang, Y.; Wang, L.; Bhering, M.; Geater, S. Lucien
err分享
err收藏
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS泛亚适应ESMO临床实践指南,用于管理局部晚期不可切除的非小细胞肺癌患者: CSCO,ISMPO,JSMO,MOS,SSO和TOS认可的ksmo-esmo倡议
err2020-02-01
err76
errOAAI
errPark, K.; Vansteenkiste, J.; Lee, K. H.; Pentheroudakis, G.; Zhou, C.; Prabhash, K.; Seto, T.; Voon, P. J.; Tan, D. S. W.; Yang, J. C. H.; Wang, J.; Babu, K. Govind; Nakayama, Y.; Alip, A.; Chua, K. L. M.; Cheng, J. C-H; Senan, S.; Ahn, Y. C.; Kim, T-Y; Ahn, H. K.; Peters, S.; Yoshino, T.; Douillard, J-Y
err分享
err收藏
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1
err2020-01-09
err33
errOAAI
errTausch, Eugen; Beck, Philipp; Schlenk, Richard F.; Jebaraj, Billy M. C.; Dolnik, Anna; Yosifov, Deyan Y.; Hillmen, Peter; Offner, Fritz; Janssens, Ann; Babu, K. Govind; Grosicki, Sebastian; Mayer, Jiri; Panagiotidis, Panagiotis; McKeown, Astrid; Gupta, Ira V.; Skorupa, Alexandra; Pallaud, Celine; Bullinger, Lars; Mertens, Daniel; Doehner, Hartmut; Stilgenbauer, Stephan
err分享
err收藏
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial
err2016-12-01
err34
PREAI
errCortes, Jorge E.; De Souza, Carmino Antonio; Ayala, Manuel; Lopez, Jose Luis; Bullorsky, Eduardo; Shah, Sandip; Huang, Xiaojun; Babu, K. Govind; Abdulkadyrov, Kudrat; Rodrigues de Oliveira, Jose Salvador; Shen, Zhi-Xiang; Sacha, Tomasz; Bendit, Israel; Liang, Zhizhou; Owugah, Tina; Szczudlo, Tomasz; Khanna, Sadhvi; Fellague-Chebra, Rafi K.; le Coutre, Philipp D.
err分享
err收藏
Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients
err2014-05-01
err103
PREAI
errReddy, B. K. M.; Lokesh, V.; Vidyasagar, M. S.; Shenoy, K.; Babu, K. G.; Shenoy, A.; Naveen, T.; Joseph, Bindhu; Bonanthaya, R.; Nanjundappa; Bapsy, P. P.; Loknatha; Shetty, Jayarama; Prasad, Krishna; Pasha, C. R. Tanvir
err分享
err收藏
HER-2 expression and response to endocrine treatment in advanced breast cancer: Is there an age differential?
errBREAST
IF7.9
err2007-03-01
err0
PREAI
errBatra, U.; Bapsy, P.; Saini, K.; Suresh, A.; Jain, A.; Sanjeevan, K.; Anupama, G.; Lokanatha, D.; Babu, K.; Devaraju, C.
err分享
err收藏